Phase 1 Overweight Subject Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

Healthy SubjectsOverweight Subject

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.111 enrolled1 locationNCT07331389

Completed

Phase 1

A Phase 1 Study to Evaluate the Safety of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers

Healthy to overweight subjects with undesirable subcutaneous fat thickness in belly

Caliway Biopharmaceuticals Australia Pty Ltd40 enrolled1 locationACTRN12618000868280